Neusoft Medical: Multiple Chinese market Leaders When it comes to Neusoft Medical, we have to go back to the 1990s. At that time, China began to frequently introduce high-end medical equipment. But these devices are not only expensive, but also many of them are second-hand products. It was not until 1997 that the first self-developed CT in China emerged, bringing a turning point to the domestic market for tube production.
The leader of innovation, Dongda Alpai, has taken advantage of computer technology to play to its strengths and avoid its weaknesses. It innovatively replaced the array processor with a PC, not only completing the technological breakthrough of the domestic CT center system, but also initiating a new innovation in international CT technology.
Subsequently, foreign CT enterprises also began to follow suit, successively unloading the expensive array processors and replacing them with cost-effective PCS. In 1994, the fantasy of "developing China's CT" finally became an ideal. In 1997, ** CT obtained SFDA certification. In 1998, Neusoft Medical Systems Co., Ltd. was officially established and launched the Neusoft CT-C2000 to the market, taking the first step towards the industrialization of domestic CT.
The four stages of Neusoft Medical's development
For over 21 years, Neusoft Medical has become one of the leading enterprises in medical imaging equipment serving the global market. In the past, Neusoft Medical has established a complete range of nine product lines. It includes eight hardware product lines - computed tomography (CT), magnetic resonance imaging (MRI), digital angiography machine (DSA), digital X-ray machine (XR), nuclear medicine imaging equipment (PET/CT), radiotherapy equipment (RT), ultrasound equipment (US), laboratory automation equipment (IVD), and the strategic product line MDaaS.
This year, Neusoft Medical has released several new products, all of which have been put on the market for sale. These include the 256-slice wide-body spectral CT - NeuViz Glory CT, the trackless suspension seven-axis intelligent vascular machine - NeuAngio 30C Hanwu DSA, and the MDaaS strategic product line.
The NeuViz Glory CT, with an ultra-fast rotational speed of 0.259 seconds, a time resolution of 25ms, and an advanced algorithm that completes 1-beat imaging at 8cm, can easily handle medical imaging challenges such as high heart rate and arrhythmia. It features a modular application for chest pain triad and stroke, facilitating efficient diagnosis by doctors. The 60kV low-dose imaging is more suitable for infant and toddler examinations as well as low-dose physical examinations.
The implantation of artificial intelligence has greatly enhanced the efficiency of doctors. The all-domain AI imaging system enables this CT to read the patient's heart information within milliseconds and generate personalized and standardized scanning plans accordingly.
The NeuAngio 30C Hanwu DSA, a trackless suspension seven-axis intelligent vascular machine with an intelligent human-computer interaction system, AI low-dose imaging platform, high heat capacity X-ray tube production, and third-generation digital flat panel detector, can meet the needs of interventional physicians to stop various long and complex surgeries. Its intelligent noise reduction low-dose platform can reduce the dose by 60%.
In addition, Neusoft Medical has developed MDaaS (Medical Devices & Data as a service) with the characteristics of "Internet sharing economy". It is based on medical devices and data by Neusoft Medical and applies technologies such as the Internet, big data and artificial intelligence. A strategic product line built for medical institutions to enhance their diagnostic and therapeutic capabilities and achieve outstanding operations.
In the next two years, Neusoft Medical will expand from a provider of imaging equipment and a producer of tubes to a provider of comprehensive clinical diagnosis and treatment solutions based on imaging equipment. Empowering clinical practice, becoming the value inventor of medical services, and forming a one-stop clinical diagnosis and treatment plan are the next key goals. And Neusoft Medical is moving towards this goal.